Syngene International Ltd.'s consolidated net profit declined 18.3% in the first quarter of financial year 2025, but was in line with analysts' estimates.
The contract research and manufacturing services firm posted a net profit of Rs 76 crore in the quarter-ended June, in comparison with Rs 93 crore in the year-ago period, according to an exchange filing on Wednesday. Analysts tracked by Bloomberg had estimated a net profit of Rs 79 crore.
Syngene International Q1 FY25 Highlights (Consolidated, YoY)
Revenue down 2% to Rs 790 crore versus Rs 808 crore (Bloomberg estimate: Rs 789 crore).
Ebitda declines 23.7% to Rs 173 crore versus Rs 227 crore (Bloomberg estimate: Rs 211 crore).
Ebitda margin at 21.9% versus 28.1% (Bloomberg estimate: 26.8%).
Net profit down 18.3% to Rs 76 crore versus Rs 93 crore (Bloomberg estimate: Rs 79 crore).
Shares of Syngene International closed 2.05% lower at Rs 742.20 apiece on the BSE, as compared with a 0.28% decline in the benchmark Sensex.
RECOMMENDED FOR YOU
Sun Pharma’s Leqselvi Launch Blocked By US Court
Nov 02, 2024
CAMS Q2 Results: Profit Rises 45% To Rs 122 Crore
Oct 28, 2024
JSW Steel Q2 Results: Profit Falls 85% On Exceptional Item, Ebitda Meets Estimates
Oct 25, 2024
M&M Financial Services Q2 Result: Profit Jumps 57% But Misses Estimates
Oct 22, 2024
POPULAR